Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC

Willem J.A. Witlox; Bram L.T. Ramaekers; Benjamin Lacas; Cecile Le Pechoux; Alexander Sun; Si Yu Wang; Chen Hu; Mary Redman; Vincent van der Noort; Ning Li; Matthias Guckenberger; Harm van Tinteren; Harry J.M. Groen; Manuela A. Joore; Dirk K.M. De Ruysscher

doi:10.1016/j.radonc.2021.09.029

Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC

Willem J.A. Witlox, Bram L.T. Ramaekers, Benjamin Lacas, Cecile Le Pechoux, Alexander Sun, Si Yu Wang, Chen Hu, Mary Redman, Vincent van der Noort, Ning Li, Matthias Guckenberger, Harm van Tinteren, Harry J.M. Groen, Manuela A. Joore, Dirk K.M. De Ruysscher

Research related

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Samenvatting

We assessed the impact of different PCI fractionation schedules (30 Gy in 10 versus 15 fractions) on brain metastases-free survival (BMFS) and toxicity in stage III NSCLC. Our results suggest that 30 Gy in 10 fractions is associated with increased toxicity, while no conclusive evidence of improving BMFS was seen with this schedule.

Originele taal-2	Engels
Pagina's (van-tot)	163-166
Aantal pagina's	4
Tijdschrift	Radiotherapy and Oncology
Volume	164
DOI's	https://doi.org/10.1016/j.radonc.2021.09.029
Status	Gepubliceerd - nov. 2021

Toegang tot document

10.1016/j.radonc.2021.09.029

Vingerafdruk

Duik in de onderzoeksthema's van 'Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC'. Samen vormen ze een unieke vingerafdruk.

Citeer dit

Witlox, W. J. A., Ramaekers, B. L. T., Lacas, B., Pechoux, C. L., Sun, A., Wang, S. Y., Hu, C., Redman, M., van der Noort, V., Li, N., Guckenberger, M., van Tinteren, H., Groen, H. J. M., Joore, M. A., & De Ruysscher, D. K. M. (2021). Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC. Radiotherapy and Oncology, 164, 163-166. https://doi.org/10.1016/j.radonc.2021.09.029

Witlox, Willem J.A. ; Ramaekers, Bram L.T. ; Lacas, Benjamin et al. / Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer : A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC. In: Radiotherapy and Oncology. 2021 ; Vol. 164. blz. 163-166.

@article{2f09d3b07c174b76be696756d73ac9f8,

title = "Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC",

abstract = "We assessed the impact of different PCI fractionation schedules (30 Gy in 10 versus 15 fractions) on brain metastases-free survival (BMFS) and toxicity in stage III NSCLC. Our results suggest that 30 Gy in 10 fractions is associated with increased toxicity, while no conclusive evidence of improving BMFS was seen with this schedule.",

keywords = "Brain metastases-free survival, Non-small cell lung cancer, Prophylactic cranial irradiation, Toxicity",

author = "Witlox, {Willem J.A.} and Ramaekers, {Bram L.T.} and Benjamin Lacas and Pechoux, {Cecile Le} and Alexander Sun and Wang, {Si Yu} and Chen Hu and Mary Redman and {van der Noort}, Vincent and Ning Li and Matthias Guckenberger and {van Tinteren}, Harm and Groen, {Harry J.M.} and Joore, {Manuela A.} and {De Ruysscher}, {Dirk K.M.}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = nov,

doi = "10.1016/j.radonc.2021.09.029",

language = "English",

volume = "164",

pages = "163--166",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

Witlox, WJA, Ramaekers, BLT, Lacas, B, Pechoux, CL, Sun, A, Wang, SY, Hu, C, Redman, M, van der Noort, V, Li, N, Guckenberger, M, van Tinteren, H, Groen, HJM, Joore, MA & De Ruysscher, DKM 2021, 'Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC', Radiotherapy and Oncology, vol. 164, blz. 163-166. https://doi.org/10.1016/j.radonc.2021.09.029

Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC. / Witlox, Willem J.A.; Ramaekers, Bram L.T.; Lacas, Benjamin et al.
In: Radiotherapy and Oncology, Vol. 164, 11.2021, blz. 163-166.

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

TY - JOUR

T1 - Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer

T2 - A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC

AU - Witlox, Willem J.A.

AU - Ramaekers, Bram L.T.

AU - Lacas, Benjamin

AU - Pechoux, Cecile Le

AU - Sun, Alexander

AU - Wang, Si Yu

AU - Hu, Chen

AU - Redman, Mary

AU - van der Noort, Vincent

AU - Li, Ning

AU - Guckenberger, Matthias

AU - van Tinteren, Harm

AU - Groen, Harry J.M.

AU - Joore, Manuela A.

AU - De Ruysscher, Dirk K.M.

PY - 2021/11

Y1 - 2021/11

N2 - We assessed the impact of different PCI fractionation schedules (30 Gy in 10 versus 15 fractions) on brain metastases-free survival (BMFS) and toxicity in stage III NSCLC. Our results suggest that 30 Gy in 10 fractions is associated with increased toxicity, while no conclusive evidence of improving BMFS was seen with this schedule.

AB - We assessed the impact of different PCI fractionation schedules (30 Gy in 10 versus 15 fractions) on brain metastases-free survival (BMFS) and toxicity in stage III NSCLC. Our results suggest that 30 Gy in 10 fractions is associated with increased toxicity, while no conclusive evidence of improving BMFS was seen with this schedule.

KW - Brain metastases-free survival

KW - Non-small cell lung cancer

KW - Prophylactic cranial irradiation

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85116762794&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2021.09.029

DO - 10.1016/j.radonc.2021.09.029

M3 - Article

C2 - 34619235

AN - SCOPUS:85116762794

SN - 0167-8140

VL - 164

SP - 163

EP - 166

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -

Witlox WJA, Ramaekers BLT, Lacas B, Pechoux CL, Sun A, Wang SY et al. Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials: Association of different PCI schedules with toxicity and BMFS in stage III NSCLC. Radiotherapy and Oncology. 2021 nov.;164:163-166. doi: 10.1016/j.radonc.2021.09.029